Determinants of anti-PD1 response and resistance in clear cell renal cell carcinoma
Lewis Au, Emine Hatipoglu, Marc Robert de Massy, View ORCID ProfileKevin Litchfield, Andrew Rowan, Rachael Thompson, Desiree Schnidrig, Fiona Byrne, Gordon Beattie, Stuart Horswell, Nicos Fotiadis, Steve Hazell, David Nicol, Scott Thomas Colville Shepherd, Annika Fendler, Robert Mason, Jan Attig, Kroopa Joshi, Imran Uddin, Pablo Becker, Mariana Werner Sunderland, Ayse Akarca, Ignazio Puccio, William Yang, Tom Lund, Kim Dhillon, Marcos Duran Vasquez, Ehsan Ghorani, Hang Xu, José Ignacio López, Anna Green, Ula Mahadeva, Elaine Borg, Miriam Mitchison, David Moore, Ian Proctor, Mary Falzon, Andrew Furness, Lisa Pickering, James L. Reading, Roberto Salgado, Teresa Marafioti, Mariam Jamal-Hanjani, George Kassiotis, Benny Chain, James Larkin, Charles Swanton, Sergio A Quezada, Samra Turajlic on behalf of the PEACE Consortium, on behalf of the TRACERx Renal Consortium
doi: https://doi.org/10.1101/2021.03.19.21253661
Lewis Au
1Cancer Dynamics Laboratory, The Francis Crick Institute, London NW1 1AT, UK
2Renal and Skin Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK
Emine Hatipoglu
2Renal and Skin Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK
3Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London WC1E 6DD, UK
4Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London WC1E 6DD, UK
Marc Robert de Massy
3Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London WC1E 6DD, UK
4Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London WC1E 6DD, UK
Kevin Litchfield
5Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London NW1 1AT, UK
Andrew Rowan
5Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London NW1 1AT, UK
Rachael Thompson
6Retroviral Immunology, The Francis Crick Institute, London NW1 1AT, UK
Desiree Schnidrig
1Cancer Dynamics Laboratory, The Francis Crick Institute, London NW1 1AT, UK
Fiona Byrne
1Cancer Dynamics Laboratory, The Francis Crick Institute, London NW1 1AT, UK
Gordon Beattie
3Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London WC1E 6DD, UK
4Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London WC1E 6DD, UK
Stuart Horswell
7Department of Bioinformatics and Biostatistics, The Francis Crick Institute, London NW1 1AT, UK
Nicos Fotiadis
8Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging, The Institute of Cancer Research and Royal Marsden Hospital, London SW3 6JJ, UK
Steve Hazell
9Department of Pathology, the Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK
David Nicol
10Department of Urology, the Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK
Scott Thomas Colville Shepherd
1Cancer Dynamics Laboratory, The Francis Crick Institute, London NW1 1AT, UK
2Renal and Skin Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK
Annika Fendler
1Cancer Dynamics Laboratory, The Francis Crick Institute, London NW1 1AT, UK
Robert Mason
2Renal and Skin Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK
Jan Attig
6Retroviral Immunology, The Francis Crick Institute, London NW1 1AT, UK
Kroopa Joshi
3Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London WC1E 6DD, UK
4Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London WC1E 6DD, UK
Imran Uddin
3Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London WC1E 6DD, UK
4Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London WC1E 6DD, UK
Pablo Becker
3Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London WC1E 6DD, UK
Mariana Werner Sunderland
3Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London WC1E 6DD, UK
Ayse Akarca
11Department of Cellular Pathology, University College London Hospital, London NW1 2BU, UK
Ignazio Puccio
11Department of Cellular Pathology, University College London Hospital, London NW1 2BU, UK
William Yang
11Department of Cellular Pathology, University College London Hospital, London NW1 2BU, UK
Tom Lund
11Department of Cellular Pathology, University College London Hospital, London NW1 2BU, UK
Kim Dhillon
11Department of Cellular Pathology, University College London Hospital, London NW1 2BU, UK
Marcos Duran Vasquez
3Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London WC1E 6DD, UK
4Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London WC1E 6DD, UK
Ehsan Ghorani
3Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London WC1E 6DD, UK
4Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London WC1E 6DD, UK
Hang Xu
5Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London NW1 1AT, UK
José Ignacio López
12Department of Pathology, Cruces University Hospital, Biocruces-Bizkaia Institute, 48903 Barakaldo, Bizkaia, Spain
Anna Green
13Department of Cellular Pathology, Guy’s & St Thomas’ NHS Foundation Trust, St Thomas’ Hospital, London SE1 7EH, UK
Ula Mahadeva
13Department of Cellular Pathology, Guy’s & St Thomas’ NHS Foundation Trust, St Thomas’ Hospital, London SE1 7EH, UK
Elaine Borg
11Department of Cellular Pathology, University College London Hospital, London NW1 2BU, UK
Miriam Mitchison
11Department of Cellular Pathology, University College London Hospital, London NW1 2BU, UK
David Moore
4Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London WC1E 6DD, UK
11Department of Cellular Pathology, University College London Hospital, London NW1 2BU, UK
Ian Proctor
11Department of Cellular Pathology, University College London Hospital, London NW1 2BU, UK
Mary Falzon
11Department of Cellular Pathology, University College London Hospital, London NW1 2BU, UK
Andrew Furness
2Renal and Skin Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK
Lisa Pickering
2Renal and Skin Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK
James L. Reading
3Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London WC1E 6DD, UK
4Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London WC1E 6DD, UK
Roberto Salgado
14Division of Research, Peter MacCallum Cancer Centre, Melbourne VIC300, Australia
15Department of Pathology, GZA-ZNA Hospitals, Wilrijk, Antwerp, Belgium
Teresa Marafioti
11Department of Cellular Pathology, University College London Hospital, London NW1 2BU, UK
Mariam Jamal-Hanjani
4Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London WC1E 6DD, UK
16Cancer Metastasis Laboratory, University College London Cancer Institute, London WC1E 6DD, UK
17Department of Medical Oncology, University College London Hospitals, London NW1 2BU, UK
George Kassiotis
6Retroviral Immunology, The Francis Crick Institute, London NW1 1AT, UK
Benny Chain
18Division of Infection and Immunity, University College London, London WC1E 6BT, UK
19University College London Cancer Institute, London WC1E 6DD, UK
James Larkin
2Renal and Skin Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK
Charles Swanton
4Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London WC1E 6DD, UK
5Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London NW1 1AT, UK
18Division of Infection and Immunity, University College London, London WC1E 6BT, UK
Sergio A Quezada
3Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London WC1E 6DD, UK
4Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London WC1E 6DD, UK
Samra Turajlic
1Cancer Dynamics Laboratory, The Francis Crick Institute, London NW1 1AT, UK
2Renal and Skin Units, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK
Data Availability
Further information and requests for resources, data and reagents should be directed to and will be fulfilled by the Lead Contact, Samra Turajlic (samra.turajlic@crick.ac.uk).
Posted March 28, 2021.
Determinants of anti-PD1 response and resistance in clear cell renal cell carcinoma
Lewis Au, Emine Hatipoglu, Marc Robert de Massy, Kevin Litchfield, Andrew Rowan, Rachael Thompson, Desiree Schnidrig, Fiona Byrne, Gordon Beattie, Stuart Horswell, Nicos Fotiadis, Steve Hazell, David Nicol, Scott Thomas Colville Shepherd, Annika Fendler, Robert Mason, Jan Attig, Kroopa Joshi, Imran Uddin, Pablo Becker, Mariana Werner Sunderland, Ayse Akarca, Ignazio Puccio, William Yang, Tom Lund, Kim Dhillon, Marcos Duran Vasquez, Ehsan Ghorani, Hang Xu, José Ignacio López, Anna Green, Ula Mahadeva, Elaine Borg, Miriam Mitchison, David Moore, Ian Proctor, Mary Falzon, Andrew Furness, Lisa Pickering, James L. Reading, Roberto Salgado, Teresa Marafioti, Mariam Jamal-Hanjani, George Kassiotis, Benny Chain, James Larkin, Charles Swanton, Sergio A Quezada, Samra Turajlic
medRxiv 2021.03.19.21253661; doi: https://doi.org/10.1101/2021.03.19.21253661
Determinants of anti-PD1 response and resistance in clear cell renal cell carcinoma
Lewis Au, Emine Hatipoglu, Marc Robert de Massy, Kevin Litchfield, Andrew Rowan, Rachael Thompson, Desiree Schnidrig, Fiona Byrne, Gordon Beattie, Stuart Horswell, Nicos Fotiadis, Steve Hazell, David Nicol, Scott Thomas Colville Shepherd, Annika Fendler, Robert Mason, Jan Attig, Kroopa Joshi, Imran Uddin, Pablo Becker, Mariana Werner Sunderland, Ayse Akarca, Ignazio Puccio, William Yang, Tom Lund, Kim Dhillon, Marcos Duran Vasquez, Ehsan Ghorani, Hang Xu, José Ignacio López, Anna Green, Ula Mahadeva, Elaine Borg, Miriam Mitchison, David Moore, Ian Proctor, Mary Falzon, Andrew Furness, Lisa Pickering, James L. Reading, Roberto Salgado, Teresa Marafioti, Mariam Jamal-Hanjani, George Kassiotis, Benny Chain, James Larkin, Charles Swanton, Sergio A Quezada, Samra Turajlic
medRxiv 2021.03.19.21253661; doi: https://doi.org/10.1101/2021.03.19.21253661
Subject Area
Subject Areas
- Addiction Medicine (238)
- Allergy and Immunology (519)
- Anesthesia (124)
- Cardiovascular Medicine (1407)
- Dermatology (158)
- Emergency Medicine (291)
- Epidemiology (10264)
- Gastroenterology (526)
- Genetic and Genomic Medicine (2611)
- Geriatric Medicine (253)
- Health Economics (495)
- Health Informatics (1727)
- Health Policy (788)
- Hematology (266)
- HIV/AIDS (563)
- Medical Education (272)
- Medical Ethics (83)
- Nephrology (286)
- Neurology (2448)
- Nursing (143)
- Nutrition (374)
- Oncology (1314)
- Ophthalmology (397)
- Orthopedics (145)
- Otolaryngology (235)
- Pain Medicine (168)
- Palliative Medicine (51)
- Pathology (341)
- Pediatrics (776)
- Primary Care Research (294)
- Public and Global Health (4987)
- Radiology and Imaging (892)
- Respiratory Medicine (680)
- Rheumatology (307)
- Sports Medicine (244)
- Surgery (296)
- Toxicology (45)
- Transplantation (140)
- Urology (108)